Ampio Pharmaceuticals

Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Investors Corporate Governance

Corporate Governance

Ampio – Business Conduct and Ethics January 2016


Charter of the Ampio Nominating and Governance Committee: VIEW


Charter of the Ampio Audit Committee: VIEW


Charter of the Ampio Compensation Committee: VIEW


Ampio – Insider Trading Policy (Amended June 2016)



Whistleblower Hotline:
Primary URL: www.intouchwebsite.com/Ampio
Primary Email: Ampio@GetInTouch.com

Ampio Stock Information

AMPE Stock Quote - delayed
LastChange
AMPE 

Latest News

Ampio Hosting Conference Call, Wednesday, July 12, 4:30 pm EDT

July 6, 2017

Ampio Injects First Patient in Final Pivotal Clinical Trial for Ampion™ BLA

June 22, 2017

Ampio Announces Appointment of Interim Chief Financial Officer

June 13, 2017

 member-logo-85

© 2017 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us